All potential acute ischemic stroke patients meeting criteria for the use of IV tPA should be offered treatment. The facts are clear, and all that remains is further provider and patient education.

Patients with acute stroke benefit from thrombolysis with IV tissue plasminogen activator (tPA). In the last decade, a number of endovascular techniques have increasingly been used to open blood ...

March 4, 2025 -- The FDA has approved the first new clot-busting drug in nearly 30 years, offering a faster way to dissolve blood clots in adults who suffer a stroke. The treatment ...